Home > Cardiology > Real-world data shows catheter ablation in AF patients lowers risk of death and HF hospitalisation

Real-world data shows catheter ablation in AF patients lowers risk of death and HF hospitalisation

Expert
Prof. Fauchier, University of Tours, France
Conference
ESC 2019
Trial
CASTLE-AF
Atrial fibrillation (AF) ablation was independently associated with a lower risk of death and hospitalisation for heart failure (HF) when analysed in a real-world setting with unselected AF patients with HF seen in hospitals. These findings are consistent with what was previously observed in recent trials with lower numbers of highly selected patients. Catheter ablation is a validated therapy for patients with symptomatic AF in order to prevent recurrences of the condition. Data from the CASTLE-AF study showed that ablation for AF in patients with HF was associated with a lower rate of death from any cause or hospitalisation for worsening HF than medical therapy. However, this was done in a highly selected environment. French researchers aimed to compare the incidence of death from any cause or hospitalisation for worsening HF in AF patients with HF after AF catheter ablation vs those not treated with AF ablation at a nationwide level in centres possibly l...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on